Roberto Lorusso of the Maastricht University Medical Center in the Netherlands discusses the Perceval valve and the PERSIST-AVR trial, which is currently underway. He focuses on the study design, while emphasizing the importance of randomized trial data for the field of cardiac surgery.
This presentation was originally given during the SCTS Ionescu University program at the 2017 Annual Meeting of the Society for Cardiothoracic Surgery in Great Britain and Ireland. This content is published with the permission of SCTS. Please click here for more information on SCTS educational programs.
